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Wang L, Steele I, Kumar JD, Dimaline R, Jithesh PV,
Tiszlavicz L, Reisz Z, Dockray GJ, Varro A. Distinct miRNA
profiles in normal and gastric cancer myofibroblasts and signifi-
cance in Wnt signaling. Am J Physiol Gastrointest Liver Physiol
310: G000 –G000, 2016. First published March 3, 2016;
doi:10.1152/ajpgi.00443.2015.—Stromal cells influence epithelial
function in both health and disease. Myofibroblasts are abundant
stromal cells that influence the cellular microenvironment by
release of extracellular matrix (ECM) proteins, growth factors,
proteases, cytokines, and chemokines. Cancer-associated myofi-
broblasts (CAMs) differ from adjacent tissue (ATMs) and normal
tissue myofibroblasts (NTMs), but the basis of this is incompletely
understood. We report now the differential expression of miRNAs
in gastric cancer CAMs. MicroRNA arrays identified differences in
the miRNA profile in gastric and esophageal NTMs and in CAMs
from stomach compared with NTMs. miR-181d was upregulated in
gastric CAMs. Analysis of differentially regulated miRNAs indi-
cated an involvement in Wnt signaling. Examination of a microar-
ray data set then identified Wnt5a as the only consistently upregu-
lated Wnt ligand in gastric CAMs. Wnt5a stimulated miR-181d
expression, and knockdown of miR-181d inhibited Wnt5a stimu-
lation of CAM proliferation and migration. Analysis of miR-181d
targets suggested a role in chemotaxis. Conditioned medium from
CAMs stimulated gastric cancer cell (AGS) migration more than
that from ATMs, and miR-181d knockdown reduced the effect of
CAM-CM on AGS cell migration but had no effect on AGS cell
responses to ATM conditioned media. The data suggest that
dysregulation of miRNA expression in gastric CAMs, secondary to
Wnt5a signaling, accounts at least in part for the effect of CAMs
in promoting cancer cell migration.
cancer; stomach; esophagus; myofibroblast; miR-181d; Wnt5a
STROMAL CELLS HAVE EMERGED IN RECENT YEARS as important
determinants of epithelial cell function in the gastrointestinal
mucosa in health and disease (7, 23, 25). There are multiple
stromal cell types, including inflammatory and immune cells,
fibroblasts, pericytes, and myofibroblasts. The latter are sparse
in many tissues, but in the gut there is normally a sheath of
myofibroblasts that surrounds intestinal crypts and gastric
glands. They may arise from activation of fibroblasts, for
example, by TGF, by transdifferentiation of mesenchymal
stem cells (26), or by epithelial-mesenchymal transition (20).
Physiologically, they play a role in wound healing. They may
also influence tumor progression (26).
Myofibroblasts are often operationally defined as expressing
-smooth muscle actin (SMA), vimentin, and fibroblast acti-
vation protein and are negative for cytokeratin and usually
desmin (7). An emerging body of evidence from multiple
experimental platforms supports the idea that there are marked
differences between different myofibroblast populations in
both health and disease. For example, microarray studies reveal
differences between myofibroblasts from different regions of
the normal gastrointestinal tract (12). Moreover, there are
marked differences in cancer at the levels of transcripts, pro-
teins, and functions. Previously, we showed that myofibro-
blasts from gastric or esophageal cancer differ from their
counterparts in adjacent tissue with evidence that myofibro-
blasts from advanced gastric tumors promote more aggressive
phenotypes in cancer cells (3, 13, 14, 17). We also showed that
esophageal cancer-associated myofibroblasts (CAMs) exhibit
increased secretion of the chemokine-like peptide chemerin,
which plays a role in mesenchymal stem cells recruitment (17).
MicroRNAs (miRNAs) are short RNAs of 22 nucleotides
that act posttranscriptionally to determine mRNA stability and
translation (1). They regulate an impressive diversity of bio-
logical processes and importantly may contribute to cancer
initiation and progression. In stomach and esophagus, previous
studies have identified differentially expressed miRNAs (8, 11,
19). However, it is not known whether miRNAs contribute to
the differences in function of different myofibroblast popula-
tions.
In view of differences in the secretomes and proteomes of
gastric or esophageal cancer-derived myofibroblasts compared
with their respective adjacent tissue myofibroblasts (ATMs), in
the present study we sought to determine whether there might
also be differences in their miRNA expression profiles com-
pared both with each other and with normal tissue myofibro-
blasts (NTMs). We now report that gastric and esophageal
NTM miRNA profiles are readily distinguishable, that gastric
CAMs differ from their respective ATMs, and that NTMs in
their miRNA profiles and Wnt5a (which is upregulated in
gastric CAMs) may act in part via miR-181d to influence
mesenchymal-epithelial signaling.
MATERIALS AND METHODS
Cells. Human primary CAMs and ATMs had previously been
generated from patients undergoing surgery for gastric or esophageal
cancer. Normal myofibroblasts from both parts (antrum and corpus) of
Address for reprint requests and other correspondence: A. Varro, Dept. of
Molecular & Cellular Physiology, Inst. of Translational Medicine, Univ. of
Liverpool, Crown St., Liverpool L69 3BX, UK (e-mail: avarro@liv.ac.uk).
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healthy stomach and esophagus had been generated from deceased
transplant donors. The patients and the myofibroblasts obtained from
them have been reported previously (6, 14). This work was approved
by the Ethics Committee of the University of Szeged, Szeged, Hun-
gary. Myofibroblasts were cultured as described previously and were
used between passages 3 and 10 (14). AGS cells were obtained from
American Type Culture Collection (Manassas, VA).
miRNA array profiling. Myofibroblasts (1.5  106) were cultured
overnight in 7.5-cm dishes, and total RNA was extracted using
miRNeasy according to the manufacturer’s instructions (Qiagen,
Crawley, UK). Samples were stored at 80°C. Total RNA and
reference samples were labeled with Hy3TM and Hy5TM fluorescence
labels, respectively (Exicon Services, Vedbaek, Denmark). The
Hy3TM-labeled samples and Hy5TM-labeled reference RNA samples
were mixed pairwise and hybridized to the miRCURYTM LNA Array
version 5 that contains capture probes targeting all miRNAs for
human, mouse, or rat registered in the miRBase version 14.0
(www.mirbase.org). After hybridization, microarrays were scanned
using an Agilent G2565BA Microarray Scanner System (Agilent
Technologies, Santa Clara, CA), and image analysis was carried out
using ImaGene 8.0 software (BioDiscovery, Hawthorne, CA). Signals
were background corrected (i.e., Normexp with offset value 10) and
normalized using the globally weighted scatterplot smoothing (LOW-
ESS) regression algorithm. The data set (GSE76221) is available at
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE76221.
Data analysis. Log2 transformed median Hy3/Hy5 ratios were
calculated using median signals on capture probe replicates and the
average log2 median ratios across samples taken. The difference in
log2 median ratio (LMR) between sample groups was calculated
and subjected to Student’s t-test (2-tailed) or ANOVA using
Bonferroni correction. The miRNA data resource was accessed at
www.mirbase.org. Principal component analysis (PCA) and hier-
archical clustering were performed using DNA Chip Analyzer
(dChip0 software, www.dchip.org). Validated target miRNAs were
obtained from the TarBase (31), miRecords (33), and MetaCore
databases (GeneGo, St. Joseph, MI). Network enrichment analysis
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Fig. 1. Principal component analysis (PCA) and cluster analysis of miRNA expression in gastric and esophageal myofibroblasts from normal tissue and cancer.
A: PCA of miRNA expression distinguishes myofibroblasts from normal gastric and oesophageal tissues (NTMs). B: PCA of miRNA expression does not
distinguish antral and corpus myofibroblasts from normal stomach. C: PCA of miRNA expression distinguishes myofibroblasts from gastric and oesophageal
cancers (CAMs); the latter includes both squamous esophageal cancer and adenocarcinoma (adeno). D: supervised hierarchical cluster analysis of miRNA
exhibiting differential expression in myofibroblasts from CAMs (c) and ATMs (a) with a dendrogram generated by dCHip above the heat map, and scale of
intensities below. To the right of the heat map are the miRNAs that are differentially expressed. The CAMs (Œ) and ATMs (o) used for studies of miR-181d
are indicated. E: supervised hierarchical clustering of miRNAs exhibiting differential expression in CAMs (c) and NTMs (n). F: supervised hierarchical clustering
of miRNAs exhibiting differential expression in ATMs (a) and NTMs (n).
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of miRNA targets was performed using MetaCore, and statistically
significant networks and pathways were identified at P 	 0.05 (FDR
corrected). Predicted targets of miR-181d were retrieved from Tar-
getScan release 5.1 (9) using a context score below 0.2 for high-
efficacy targets. Gene expression profiles of gastric myofibroblasts,
previously carried out using GeneChip Human Genome U133 Plus 2.0
array and deposited at http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?accGSE44740, (3) were used to determine the abundance of
potential miRNA regulators and target transcripts.
MicroRNA quantitative PCR. MicroRNA reverse-transcription
polymerase chain reaction [quantitative PCR (qPCR)] analysis was
used to validate the miRNA array data. Thus, 50 ng of total RNA was
reverse transcribed in 10-
l reactions using miRCURY LNA Univer-
sal RT microRNA PCR, polyadenylation, and cDNA synthesis re-
agents (Exicon) in triplicate. cDNA was diluted 100 times, and 4 
l
was used in 10-
l PCR reactions according to the protocol for
miRCURY LNA Universal RT microRNA PCR. Each miRNA was
assayed once by RT-PCR. The amplification was performed in a
LightCycler 480 Real-Time PCR System (Roche, Basel, Switzerland)
in 384-well plates. MicroRNA qPCR analysis was also carried out
using the Ambion mirVana miRNA isolation reagents (Thermo Fisher
Scientific, Waltham, MA) and a 7500 real-time PCR system (Applied
Biosystems, Warrington, UK) with All-in-One miRNA qRT-PCR
(GeneCopoeia, Rockville, MD) according to the manufacturer’s pro-
tocol in triplicate. Sequences for miRNA primers were as follows:
miR-181d, 5=-AAC AUU CAU UGU UGU CGG UGG GU; miR-29b,
5=-UAG CAC CAU UUG AAA UCA GUG UU; miR-214, 5=-ACA
GCA GGC ACA GAC AGG CAG U; miR-424, 5=-CAG CAG CAA
UUC AUG UUU UGA A; and miR-125a-5p, 5=-UCC CUG AGA
CCC UUU AAC CUG UGA.
LightCycler 480 software was used to determine the Cp value and
to generate amplification and melting curves. LinRegPCR (11.5)
software was used to determine the amplification efficiency. The
average amplification efficiency was used to correct raw Cp values.
Reference (or housekeeping) miRNAs for comparison were sought
using the SLqPCR algorithm (www.bioconductor.org), which identi-
fied miR-125a-5p, miR-24, and miR-22 as appropriate stable refer-
ence miRNAs. The geometric means of these were then used to
normalize measurements on a well-to-well basis. In some experi-
ments, SDS version 1.4 software was used to determine the CT value
and product melting curves for assays of miR-181d, which were
normalized to miR-125a-5p abundance in the same sample. Relative
miRNA abundance was expressed using the 2CT method (22).
qPCR analysis. cDNAs were prepared by reverse transcribing RNA
(2 
g) with AMV reverse transcriptase (Promega, Southampton, UK)
and oligoDT (Promega). Real-time PCR was carried out in an ABI
7500 thermocycler (Applied Biosystems) using Precision 2 real-
time PCR master mix (Primer Design, Southampton, UK) and 5=-
FAM, 3=-TAMRA double-dye probes (Eurogentec, Southampton,
UK). Primers used for PCR analyses were as follows: hGAPDH
probe, CGT CGC CAG CCG AGC CAC A; hGAPDH forward, GCT
CCT CCT GTT CGA CAG TCA; hGAPDH reverse, ACC TTC CCC
ATG GTG TCT GA; hWnt5a probe, TTT CTT TTC TGC CTC ACC
CCT TTG TCT CCA; hWnt5A forward, GAA ATG CGT GTT GGG
TTG AAG; and hWnt5a reverse, AAG TAA TGC CCT CTC CAC
AAA G. Standard curves were generated using serial dilutions of
cDNA template corresponding to the relevant gene amplicon ligated
into pGEM-T Easy (Promega).
Western blot analysis. Cellular protein was extracted using RIPA
lysis buffer containing 1% vol/vol Phosphatase Inhibitor Cocktail set
II and 1% vol/vol Protease Inhibitor Cocktail Set III, EDTA-Free
(Merk Millipore, Darmstadt, Germany). Total protein was determined
using DC Protein Assay (Bio-Rad Laboratories, Hemel Hempstead,
UK). Proteins were resolved by SDS-PAGE electrophoresis, trans-
ferred to nitrocellulose (Amersham Pharmacia Biotech, Buckingham-
shire, UK), and incubated with antibodies to Wnt5A (R & D Systems,
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Fig. 2. Functional significance of increased miR-
181d expression. A: increased miR-181d expres-
sion relative to miR-125a-5p in pairs of gastric
CAMs and their respective ATMs; n  4, P 	
0.05. B: decreased relative abundance of miR-
181d after miR-181d knockdown compared with
control CAMs transfected with a scrambled se-
quence. C: representative images of 5-ethynyl-2=-
deoxyuridine (EdU)-labeled cells (arrows) in
control samples transfected with a scrambled
sequence (i) and after mir-181d knockdown (ii);
nuclei stained with DAPI. Scale bar, 50 
m. D:
decreased EdU incorporation in CAMs following
miR-181d knockdown (miR-181d-KD) com-
pared with myofibroblasts transfected with
scrambled controls; n  3 independent experi-
ments, P 	 0.05. E: representative images of
Boyden chamber experiments showing migrating
control cells (arrows; i) and after miR-181-d
knockdown (ii). F: decreased migration of CAMs
after miR-181d knockdown compared with CAMs
transfected with scrambled controls; n  3, P 	
0.05.
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Abingdon, UK), followed by horseradish peroxidase (HRP)-conju-
gated secondary antibody and detection by incubation with Super-
Signa West Pico Chemiluminescent Substrate (Pierce) and exposure
to HyperFilm (Amersham Pharmacia Biotech). Samples of cell ex-
tracts were reprobed for GAPDH (Biodesign, Saco, Maine, USA) to
normalise for protein loading. Densitometric analysis of the band
intensities from Western blot analysis was performed using ImageLab
software v2.1 (Bio-Rad).
Immunohistochemistry. Samples of the gastric cancers that had
been used to generate myofibroblasts were fixed in 10% neutral-
buffered formalin, paraffin-embedded, and processed for immunohis-
tochemical detection of Wnt5a using mouse monoclonal antibody to
Wnt5a (R & D Systems) and En Vision FLEX/HRP (Dako, Carpin-
teria, CA) as secondary antibody. Antigen retrieval was performed by
incubating at pH 9.0, 93°C, for 15 min, as described previously (30).
miR-181d knockdown. Knockdown of miR-181d was carried out
using the miArrest miRNA inhibitor clone (3 
g) (GeneCopoeia) with
the appropriate control vector (3 
g), using Amaxa Human Dermal
Fibroblast Nucleofector reagents (Lonza, Basel, Switzerland) and a
Nucleofector I device according to the manufacturer’s instructions.
Cells were used for further experiments 48 h posttransfection.
Magnetofection and luciferase assays. Gastric myofibroblasts (105
cells/well) were seeded on six-well plates and incubated overnight in
supplemented DMEM. Transfection solution was prepared according
to the manufacturer’s protocol and consisted of 1 
g of Cignal
TCF/LEF Reporter (luciferase) construct (Qiagen), 6 
l of TransFast
transfection reagent (Promega), and 2 
l of CombiMag (OZ Biosci-
ences, Marseille, France). Posttransfection (24 h), myofibroblasts
were lysed for the luciferase assay. Luciferase assay buffer II and Stop
& Glo Reagent were prepared according to the manufacturer’s (Pro-
mega) protocol. Activities of firefly luciferase and Renilla luciferase
were measured by dual luciferase assay, using a Lumat LB 9507 tube
luminometer (Berthold Technologies, Bad Wildbad, Germany) in
triplicate. Data were presented as a ratio of firefly luciferase to Renilla
luciferase values.
5-Ethynyl-2=-deoxyuridine incorporation. Gastric myofibroblasts
(104/well) were seeded and incubated overnight in culture media,
followed by serum starvation for 24 h. Proliferation was assessed by
incorporation of 5-ethynyl-2=-deoxyuridine (EdU; 10 
M) and pro-
cessing of samples using Click-iT (Invitrogen, Paisley, UK). Each
experiment was performed in triplicate. EdU-positive cells were
visualised on a Zeiss AxioCam HRM fluorescence microscope (Carl
Zeiss, Welwyn Garden City, UK) on a 40 objective lens, counting
the total number of cell nuclei in 10 different fields using DAPI (blue;
Vector Laboratories, Peterborough, UK) and EdU positive nuclei
using FITC (green).
Boyden chamber migration assays. The migration of gastric myo-
fibroblasts and AGS cells was studied using 8-
m pore Biocoat
control inserts on 24 well-plates (BD Biosciences, Oxford, UK). Cell
suspensions were diluted in serum-free DMEM and added to the
upper chamber containing 104 cells. Conditioned medium (CM) or
serum-free DMEM containing 1 
g/ml recombinant Wnt5a was
added to each of the bottom chambers. Cells were incubated for
16 h, and migrated cells were stained on the lower surface of the
membranes using the Reastain Quick-Diff kit (Reagena, Takojan-
tie, Finland). Membranes were removed and placed on microscope
slides with immersion oil (Sigma-Aldrich, Darmstadt, Germany)
underneath and covered with cover slips. Cells were visualized and
counted from five different fields using a 10 objective lens and a
Zeiss Axiovert25 Microscope. Each experiment was performed in
triplicate.
Statistics. Results are expressed as means  SE unless stated
otherwise. Student’s t-test was used to determine statistical signifi-
cance of results and considered significant at P 	 0.05 unless stated
otherwise.
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Fig. 3. MetaCore analysis of differently expressed
miRNA targets in CAMs identifies a role in Wnt
signaling. A: networks defined by enrichment of
targets of the 10 miRNAs exhibiting significant
differential abundance in a group of 12 CAMs
compared with their respective adjacent tissue
myofibroblasts (ATMs). B: Wnt signaling was the
only network that exhibited significant enrich-
ment [x-axis, log (P value)] of targets of miR-
NAs identified as differentially expressed when
each of the 12 CAMs was compared individually
with their respective ATMs. C: increased TCF/
LEF firefly luciferase activity normalized to Re-
nilla luciferase in CAMs compared with ATMs;
n  3, P 	 0.05. PI3K, phosphatidylinositol
3-kinase; TGF, transforming growth factor-.
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RESULTS
Distinct global miRNA expression profiles in normal gastric
and esophageal myofibroblasts. An average of 25 and 27% of
the microarray probes was detected in gastric NTMs and
esophageal NTMs, corresponding to 276 and 300 mature
human miRNAs, respectively. Comparison of the global
miRNA data by PCA revealed distinct clusters of gastric
NTMs and esophageal NTMs (Fig. 1A). Interestingly, normal
antral- and corpus-derived myofibroblasts clustered together
(Fig. 1B).
Different miRNA expression profiles in myofibroblasts from
cancer and control tissue. The same methodology was then
extended to the analysis of myofibroblasts from cancer. There
were clear differences between gastric and esophageal CAMs
in PCA (Fig. 1C). Supervised hierarchical clustering of differ-
entially expressed miRNAs (see MATERIALS AND METHODS) did
not segregate gastric CAMs vs. ATMs (Fig. 1D); however,
there was segregation of gastric CAMs from NTMs (Fig. 1E)
and of gastric ATMs from NTMs (Fig. 1F).
Validation of microarray analysis. The microarray data were
initially validated by applying qPCR to gastric and esophageal
myofibroblasts for three miRNAs (miR-29b, miR-214, and
miR-424). These were selected on the basis that they were well
expressed in both tissues, which gave a relatively large
sample size for comparison. Thus, there was a positive
correlation between microarray and qPCR analyses for miR-
29b (Pearson correlation coefficient: 0.901, P 	 0.05, n 
43), miR-214 (Pearson correlation coefficient: 0.685, P 	
0.05, n  21), and miR-424 (Pearson correlation coefficient:
0.926, P 	 0.05, n  31).
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Fig. 4. Increased expression of Wnt5a in
CAMs. A: quantification of Wnt5a mRNA
abundance relative to GAPDH obtained from
archived microarray data for 12 pairs of
CAMs and their respective ATMs; P 	 0.05.
B: quantification of Wnt5a mRNA expres-
sion relative to GAPDH determined by quan-
titative PCR (qPCR) for pairs of CAMs and
ATMs, n  9; P 	 0.05. C: densitometrical
quantification of Wnt5a protein abundance
relative to GAPDH determined by Western
blot for pairs of CAMs and ATMs; n  6,
P 	 0.05. D: representative Western blots of
Wnt5a and GAPDH of CAMs and ATMs. E:
immunohistochemical localization of Wnt5a
in gastric cancer and adjacent tissues. Arrows
indicate staining in stromal cells in cancer
(i, 10; ii, 20; iii, 40) compared with
adjacent cancer tissue (iv, 40) or control
tissue (v, 10; vi, 40).
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Of the miRNAs that exhibited significant differential abun-
dance in gastric CAMs vs. ATMs (Fig. 1E), miR-181d exhib-
ited the highest mean difference (Fig. 2A). For validation of
miR-181d by qPCR, we selected three pairs of CAMs and
ATMs, including the two that exhibited the widest difference
in miR-181d expression; there was good agreement between
qPCR and microarrays in miR-181d relative abundance in
CAMs/ATMs (microarrays 1.7  0.4, compared with 1.8 
0.3 by qPCR). The two pairs of CAMs and ATMs exhibiting
the highest difference in expression were then used for func-
tional validation studies. In particular, the relevance of miR-
181d to the CAM phenotype was indicated by the observation
that knockdown of miR-181-d (Fig. 2B) significantly reduced
both incorporation of EdU (Fig. 2, C and D) and migration in
Boyden chambers (Fig. 2, E and F).
Network analysis of differentially abundant miRNAs in
CAMs vs. ATMs. There were 10 miRNAs that exhibited sig-
nificant differential abundance when the data from gastric
CAMs and ATMs as a whole were compared, and for which
published and validated targets were available in MetaCore,
TargetScan5.1, TarBase, or miRecods. The validated targets
for these miRNAs were then taken for network analysis in
MetaCore. The top three networks exhibiting significant en-
richment were implicated in proliferation and Wnt signaling
(Fig. 3A). To determine whether there was interpatient vari-
ability in enriched networks, we then performed a pairwise
comparison of CAMs and ATMs from each of 12 patients. For
this analysis, we identified miRNAs exhibiting 50% differ-
ence in abundance in each pair; as before, validated targets of
these miRNAs were then used for network analysis in Meta-
Core. This analysis revealed Wnt signaling as significantly
enriched in all 12 pairs; this was the only network to be
significantly enriched in all cases (Fig. 3B). However, in
addition, regulation of proliferation was enriched in 11 of 12
pairs of CAMs and ATMs.
Consistent with these findings, we have reported previously
that CAMs exhibit increased proliferation, as well as increased
migration and reduced apoptosis, compared with ATMs (14,
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Fig. 5. Increased miR-181d expression by
Wnt5a. A: increased miR-181d expression
determined by qPCR in response to Wnt5a (1

g/ml), but not Wnt3a (1 
g/ml), expressed
relative to miR125a-5p; n  3, Horizontal
double arrows, P	 0.05, ANOVA. B: Wnt5a
and IGF-II (100 ng/ml) have similar effects in
stimulating EdU incorporation. C: Wnt5A
and IGF-II have similar effects in stimulating
migration in Boyden chambers. D: represen-
tative image showing EdU incorporation (ar-
rows) in CAMs in response to Wnt5a alone
(i) and Wnt5a after knockdown of miR-181d
(ii); nuclei stained with DAPI. Scale bar, 50

m. E: EdU incorporation in CAMs in re-
sponse to Wnt5a is significantly reduced by
miR-181d knockdown; n  3, P 	 0.05. F:
representative images of Boyden chamber ex-
periments showing migrating cells (arrows)
in response to Wnt5a alone (i) and Wnt5a
after miR-181-d knockdown (ii). G: Wnt5a-
stimulated migration (control) is reduced af-
ter miR-181d knockdown; n  3, P 	 0.05.
*P 	 0.05.
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17). However, the identification of Wnt signaling as a promi-
nent differentially regulated network has not previously re-
ceived attention and was considered sufficiently interesting to
merit further investigation. To this end, we initially explored
the potential activation of Wnt signaling in CAMs using a
TCF/LEF reporter assay. Luciferase activity was significantly
higher in CAMs than in ATMs (Fig. 3C), indicating that the
canonical signaling pathway is activated in CAMs.
Differential Wnt5a abundance in CAMs. There is evidence
that Wnt signaling regulates miR-181 family members (15). To
understand the possible role of Wnt signaling in gastric CAMs,
we first examined gene array data to determine the pattern of
expression of Wnt ligands with a view to identifying any that
exhibited differential expression in CAMs. Out of 18 Wnt
ligands represented on the array, only Wnt5a and Wnt5b were
detected in all 12 pairs of CAMs and ATMs. In 10 pairs, the
abundance of Wnt5a was 50% greater in CAMs than in
ATMs, whereas in the other two it was unchanged; overall, the
increased expression in CAMs was statistically significant
(Fig. 4A). In contrast, Wnt5b was increased in only five pairs
of CAMs compared with ATMs. Wnt2b was detected in 8
pairs, and the remainder (Wnt1, -2, -3, -4, -6, -7a, -7b, -8a, -8b,
-9a, -9b, -10a, -10b, -11, and -16) were identified in fewer than
half of the pairs of CAMs and ATMs. The increased expression
of Wnt5a in CAMs was then confirmed by qPCR (Fig. 4B).
Moreover, when we examined Wnt5a expression by Western
blot, we found increased abundance in CAMs compared with
their respective ATMs (Fig. 4, C and D). In addition, immu-
nohistochemistry identified Wnt5a in stromal cells in gastric
cancer (Fig. 4E); a similar proportion of stromal cells (75%)
showed Wnt5a expression in cancers and adjacent tissue, but
there was increased staining intensity in the tumor-associated
cells.
Wnt5a stimulates mir-181d expression. Because Wnt5a was
increased in gastric CAMs, we then examined whether miR-
181d might mediate Wnt5a actions. There was a significant
increase in miR-181d abundance in gastric myofibroblasts
exposed to Wnt5a (1 
g/ml), but not Wnt3a (1 
g/ml), used for
comparison (Fig. 5A). When CAMs were treated with Wnt5a,
there was stimulation of EdU incorporation that was compa-
rable to that seen with IGF-II (100 ng/ml) used as a positive
control (Fig. 5B); moreover, Wnt5a stimulated migration in
Boyden chambers, and the response was similar to that with
IGF-II (Fig. 5C). After knockdown of mi-R181d, EdU incor-
poration in response to Wnt5a was reduced (Fig, 5, D and E).
Similarly, Wnt5a-stimulated migration was significantly re-
duced after knockdown of mi-R181d (Fig. 5, F and G). The
specificity of the response was indicated by the fact that
miR-181d did not inhibit the migratory response to IGF-II
(IGF-II, 61.3  5.1 cells/field; IGF-II and miR-181d knock-
down, 57.7  3.5).
Network analysis of miR-181d targets identifies chemotactic
networks. We then examined in MetaCore the published and
validated targets of miR-181d; in view of the importance of
myofibroblasts in determining the tumor microenvironment,
we focused on targets encoding extracellular proteins. This
analysis identified regulation of chemotaxis as the top enriched
network (Fig. 6A). This was considered interesting since it is
known that conditioned medium (CM) from CAMs stimulates
cancer cell migration more than CM from ATMs (14). To
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Fig. 6. MetaCore analysis of differently expressed
miRNA target genes encoding secreted proteins in CAMs
identifies a role in chemotaxis. A: networks enriched by
targets encoding secreted proteins of significantly differ-
ently expressed miRNAs in CAMs compared with ATMs.
B: conditioned media (CM) from control transfected
CAMs (CAM CM) stimulates migration of gastric cancer
cells (AGS) in Boyden chambers, but this is reduced after
miR-181d knockdown in the CAMs (CAM CM, 181d-
KD); in contrast, CM from ATMs (AMT CM) has a
smaller effect on AGS cell migration, and pretreatment of
the ATMs to knockdown miR-181d (ATM CM, 181d-
KD) has no effect on the response; n  3 horizontal
arrows, P 	 0.05, ANOVA.
G7DIFFERENTIAL EXPRESSION OF miRNA IN GASTRIC MYOFIBROBLASTS
AJP-Gastrointest Liver Physiol • doi:10.1152/ajpgi.00443.2015 • www.ajpgi.org
F4
F5
F6
tapraid4/zh3-agij/zh3-agij/zh300916/zh37085d16z xppws S5 3/16/16 13:24 MS: GI-00443-2015 Ini: 05/DU/DLH
determine whether miR-181d is implicated in this mechanism,
gastric cancer AGS cells were incubated with CAM CM after
miR-181d knockdown. CM from CAMs significantly stimu-
lated AGS cell chemotaxis, and there was a significant de-
crease in migration of AGS cells in CM from miR-181d
knockdown CAMs (Fig. 6B). In contrast, ATM CM stimulated
a smaller migratory response, and knockdown of miR-181d in
the ATMs had no effect (Fig. 6B).
DISCUSSION
The main finding of this study is that there are different
miRNA profiles in myofibroblasts from normal stomach and
esophagus and in gastric cancer-derived myofibroblasts com-
pared with control tissue. We show that miR-181d is increased
in gastric CAMs and mediates the actions of Wnt5a, which is
itself upregulated in these cells. Medium from CAMs stimu-
lates cancer cell migration, and this is decreased by miR-181d
knockdown. The data suggest that differential regulation of
miRNAs in myofibroblasts may promote an aggressive pheno-
type in gastric cancer cells.
There is growing appreciation of the diversity of cells of
fibroblastic lineages in the gastrointestinal tract with distinct
transcriptomes in cells from different regions (12) as well as in
cells from cancer or adjacent tissue (14, 17). There are likely to
be multiple underlying mechanisms, and, for example, it is
already known that there are epigenetic differences between
gastric CAMs and ATMs (16). The present data now identify
variable expression of miRNAs in different myofibroblast
populations. We were readily able to distinguish the miRNA
profiles of gastric and esophageal myofibroblasts from normal
healthy tissue as well as from gastric cancer and normal tissue.
Therefore, the data emphasize the importance of selecting the
appropriate myofibroblasts for studies of stromal-epithelial cell
function. The physiological significance of the heterogeneity in
gastrointestinal myofibroblasts remains uncertain. In the pres-
ent study we focused on gastric cancer, but in the future it
should be possible to perform similar studies in esophagus. The
present studies identify dysregulation of miR-181d and a link
to increased Wnt5a expression, both of which have previously
been associated with gastric cancer (2, 18).
The relationship between miRNA profiles and Wnt signaling
in myofibroblasts is complex. Both the canonical and nonca-
nonical Wnt pathways have been linked to myofibroblast
function. The canonical pathway has been implicated in dif-
ferentiation of myofibroblasts from fibroblasts and mesenchy-
mal stem cells (4, 29). Moreover, the present observations on
increased activity in gastric CAMs of a TCF/LEF reporter
construct are consistent with enhanced canonical pathway
activation. In addition, however, it is known that the nonca-
nonical ligand Wnt5a is expressed in gastrointestinal myofi-
broblasts and can be upregulated in response to stimulation,
whereas a range of other Wnt family members were either
absent or unchanged (21). Our evidence suggests that Wnt5a is
the predominant Wnt ligand to be expressed in gastric myofi-
broblasts. Several lines of evidence (microarray, qPCR, West-
ern blot, immunohistochemistry) point to increased expression
of Wnt5a in CAMs compared with ATMs. We showed that
Wnt5a stimulated proliferation, migration, and miR-181d ex-
pression in gastric myofibroblasts and that knockdown of
miR-181d inhibited the proliferative and migratory responses
to Wnt5a. Therefore, the data provide a functional framework
for interpreting previous studies showing Wnt5a upregulation
in gastric cancer but not gastric cancer cell lines, which was
considered to suggest an association with the presence of
stroma (27). Even so, the mechanism responsible for increased
Wnt5a expression in gastric cancer remains unknown, and
further work is required here. Nevertheless, since Wnt5a ex-
pression is linked to poor outcome (18) in gastric cancer, the
identification of a downstream pathway involving miR-181d
may prove useful in diagnosis and therapy. In this context, it is
worth mentioning that other studies have reported the increased
expression Dickkopf-1 in gastric cancer (10) and secreted
frizzled related protein-1 (24), both of which were associated
with poor outcome and both of which are potential modulators
of Wnt signaling, providing further evidence of the complexity
of the system.
There is increased expression of miR-181d in a number of
cancers, including acute myeloid leukemia (28) and gastric
cancer (2), although there is downregulation in gliomas (5). In
liver, increased expression of miR-181d is associated with
progression to hepatocellular carcinoma; in this setting, miR-
181d is regulated by TGF, and one of its targets is tissue
inhibitor of metalloproteinase 3 (TIMP3) (32). Our findings
indicate that knockdown of miR-181d in CAMs reduced the
effect of CAM-CM on AGS cell migration, pointing to miR-
181d suppression of an inhibitor of migration. There is in-
creased MMP activity in gastric CAM CM that contributes to
stimulation of cancer cell migration (13) so that suppression by
miR-181d of MMP inhibitors such as TIMP3 provides a
mechanism for understanding how expression of miR-181d in
stromal cells promotes an aggressive phenotype in gastric
cancer cells.
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